Inhibitory effect of valproic acid on ovarian androgen biosynthesis in rat theca-interstitial cells

被引:5
作者
Fisseha, Senait [1 ,2 ]
Towns, Roberto [1 ,2 ]
Harada, Miyuki [1 ,2 ]
Peegel, Helle [1 ,2 ]
Menon, K. M. J. [1 ,2 ]
机构
[1] Univ Michigan, Sch Med, Dept Obstet Gynecol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
Theca-interstitial cells; Androgen synthesis; hCG; Steroidogenesis; Androstenedione; Valproic acid; PCOS; B TYPE-I; LEYDIG-CELLS; FEMALE RATS; EPILEPSY; WOMEN; TESTOSTERONE; EXPRESSION; ENDOCRINE; SECRETION; THERAPY;
D O I
10.1007/s12020-009-9287-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the study was to evaluate the effect of valproic acid (VPA) on ovarian androgen biosynthesis in primary cultures of theca-interstitial (T-I) cells isolated from rat ovaries. Ovarian T-I cells were cultured with VPA in the presence or absence of hCG. VPA did not increase basal or hCG-stimulated androgen synthesis when added to primary cultures of T-I cells. However, the addition of VPA caused a marked concentration-dependent inhibitory effect on hCG-stimulated androstendione synthesis. Treatment of T-I cells with 8-Bromo-cAMP resulted in a marked increase in the production of androstenedione, and VPA inhibited this stimulatory effect, suggesting that the mechanism of VPA's inhibitory effect on androstenedione production occurs at a step after second messenger activation. Treatment of T-I cells with hCG resulted in a significant increase in the mRNA expression of steroidogenic enzymes CYP17A1 and 17 beta-hydroxysteroid dehydrogenase. Addition of VPA sharply blunted the stimulatory effect of hCG, reducing the mRNA expression of the steroidogenic enzymes to basal levels. In conclusion, VPA exerts an inhibitory effect on hCG-stimulated androgen synthesis in rat T-I cells.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 28 条
  • [1] Polycystic ovary syndrome in women using valproate: A review
    Bilo, Leonilda
    Meo, Roberta
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (10) : 562 - 570
  • [2] BRUGUEROLLE B, 1982, CR SOC BIOL, V176, P359
  • [3] Valproate is an anti-androgen and anti-progestin
    Death, AK
    McGrath, KCY
    Handelsman, DJ
    [J]. STEROIDS, 2005, 70 (14) : 946 - 953
  • [4] Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey
    Ferin, M
    Morrell, M
    Xiao, EN
    Kochan, L
    Qian, F
    Wright, T
    Sauer, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2908 - 2915
  • [5] Effects of Anticonvulsants on human P450c17 (17α-hydroxylase/17,20 lyase) and 3ß-hydroxysteroid dehydrogenase type 2
    Flück, CE
    Yaworsky, DC
    Miller, WL
    [J]. EPILEPSIA, 2005, 46 (03) : 444 - 448
  • [6] AN IMPROVED DIPHENYLAMINE METHOD FOR ESTIMATION OF DEOXYRIBONUCLEIC ACID
    GILES, KW
    MYERS, A
    [J]. NATURE, 1965, 206 (4979) : 93 - &
  • [7] Valproate-induced alterations in testosterone, estradiol and progesterone secretion from porcine follicular cells isolated from small- and medium-sized ovarian follicles
    Gregoraszczuk, E
    Wojtowicz, AK
    Tauboll, E
    Ropstad, E
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (07): : 480 - 485
  • [8] TEMPORAL-LOBE EPILEPSY - AN EXTRAHYPOTHALAMIC PATHOGENESIS FOR POLYCYSTIC OVARIAN SYNDROME
    HERZOG, AG
    SEIBEL, MM
    SCHOMER, D
    VAITUKAITIS, J
    GESCHWIND, N
    [J]. NEUROLOGY, 1984, 34 (10) : 1389 - 1393
  • [9] POLYCYSTIC OVARIES AND HYPERANDROGENISM IN WOMEN TAKING VALPROATE FOR EPILEPSY
    ISOJARVI, JIT
    LAATIKAINEN, TJ
    PAKARINEN, AJ
    JUNTUNEN, KTS
    MYLLYLA, VV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (19) : 1383 - 1388
  • [10] Inhibition of human aromatase complex (CYP19) by antiepileptic drugs
    Jacobsen, N. W.
    Halling-Sorensen, B.
    Birkved, F. K.
    [J]. TOXICOLOGY IN VITRO, 2008, 22 (01) : 146 - 153